Loading...
Please wait, while we are loading the content...
Similar Documents
Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Hansel, Trevor T. Neighbour, Helen L. Erin, Edward M. Tan, Andrew J. Tennant, Rachel C. Maus, Joachim G. Barnes, Peter J. |
| Copyright Year | 2005 |
| Abstract | INTRODUCTION Inhaled anticholinergic drugs are effective bronchodilators in the treatment of COPD, and tiotropium bromide has recently been introduced as a once-daily bronchodilator for use as a maintenance treatment. Racemic glycopyrrolate is an anticholinergic drug that has been used orally to control gastric acidity, parenterally as an antisialogogue and to reverse neuromuscular blockade, and has been studied by inhalation for asthma and COPD. DESIGN AND OBJECTIVE We investigated the duration of protection against the constrictor effects of inhaled methacholine of a single dose of inhaled nebulized racemic glycopyrrolate (0.5, 1.0, and 2.0 mg) compared with ipratropium bromide (0.5 mg) and placebo in 10 atopic asthmatic volunteers in a double-blind, five-way, crossover study. RESULTS Protection against methacholine-induced bronchospasm after administering glycopyrrolate was maintained to 30 h, the last time point measured. Both bronchodilatation and bronchoprotection were significantly longer with glycopyrrolate than after ipratropium bromide, and bronchoprotection was significant at all time points from 2 to 30 h compared to placebo. Dryness of the mouth and nose was described in 18% of patients after the highest dose of glycopyrrolate. CONCLUSIONS The prolonged bronchodilator response and the protection against methacholine-induced bronchospasm demonstrated in asthma suggests that inhaled racemic glycopyrrolate would be superior to ipratropium bromide for treatment of stable COPD. |
| Starting Page | 151 |
| Ending Page | 157 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/22032/1974.pdf |
| PubMed reference number | 16236844v1 |
| Volume Number | 128 |
| Issue Number | 4 |
| Journal | Chest |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Administration procedure Anticholinergic Agents Asthma Atopy Bronchial Spasm Bronchodilator Agents Chronic Obstructive Airway Disease Glycopyrrolate Inspiration function Ipratropium Methacholine Oral cavity Patients Racemate tiotropium bromide |
| Content Type | Text |
| Resource Type | Article |
